Cincinnati-based CRO Kendle has appointed Pierre Geoffroy, M.D., C.M., MSc, FCFP vice president, early stage, effective immediately. Dr. Geoffroy brings nearly two decades of clinical development experience to the position. He will oversee the development of early stage programs for customers worldwide, providing medical expertise and clinical insights for the development of safe and effective early-stage clinical trials. Dr. Geoffroy will be based out of Kendle's early stage unit in Toronto and will report directly to Stephen Cutler, Ph.D., president and CEO.
Dr. Geoffroy joins Kendle from Lambda Therapeutic Research, where he served most recently as chief medical officer, vice president and principal investigator. He also has served in senior clinical roles at multiple global biopharmaceutical corporations, including as senior director, clinical at Sanofi Pasteur; head of clinical research and senior advisor, drug development at Wyeth Ayerst; regional director at Wyeth Research Canada; executive director, medical affairs at Hoffmann La Roche; and associate medical director at SmithKline Beecham.
Dr. Geoffroy earned his medical degree, a Master of Science degree in Epidemiology and a Bachelor of Science in Nutrition, from McGill University. He also holds a Master of Science in Nutrition from the University of Toronto. He is certified by the Corporation des Medecins du Quebec, the College of Family Physicians of Canada, the Medical Council of Canada and the College of Physicians and Surgeons of Ontario. He was awarded a fellowship in the College of Family Physicians of Canada in 1995.